Agarwal 环扎技术在腹腔镜根治性肾输尿管切除术中处理远端输尿管的长期肿瘤学结局
该研究描述了 Agarwal 环扎技术在腹腔镜根治性肾输尿管切除术(LRNU)中处理远端输尿管的方法,并回顾性分析了 76 例上尿路尿路上皮癌(UTUC)患者的长期肿瘤学结局。结果显示膀胱袖口均完整切除且远端切缘阴性,无膀胱周围复发或穿刺孔转移,5 年膀胱、局部和对侧无复发生存率分别为 59.6%、89.0% 和 93.5%,5 年总生存率和癌症特异性生存率分别为 70.3% 和 84.7%。
要点
- Agarwal 环扎技术可确保膀胱袖口整块切除并减少肿瘤溢出。
- 76 例患者中远端切缘均阴性,无膀胱周围复发或穿刺孔转移。
- 5 年膀胱、局部、对侧无复发生存率分别为 59.6%、89.0%、93.5%。
核心结论
- Agarwal 环扎技术符合欧洲泌尿外科学会指南的肿瘤学原则,长期肿瘤学结局满意。
主要发现
- 中位年龄 71.5 岁,中位手术时间 4.3 小时,所有患者膀胱内输尿管段和膀胱袖口均完整切除。
- 远端切缘均阴性,仅 2 例肿瘤累及环周切缘,无膀胱周围复发或穿刺孔转移。
- 5 年膀胱、局部、对侧无复发生存率分别为 59.6%、89.0% 和 93.5%,5 年无转移生存率为 73.5%。
- 5 年总生存率和癌症特异性生存率分别为 70.3% 和 84.7%。
临床怎么用
- 在 LRNU 中可采用 Agarwal 环扎技术处理远端输尿管,以降低肿瘤溢出风险并实现膀胱袖口整块切除。
局限性
- 回顾性研究,样本量 76 例,来自参与中心,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe the Agarwal loop-ligation technique for the management of the distal ureter during laparoscopic radical nephroureterectomy (LRNU) for upper tract urothelial carcinoma (UTUC) and report on long-term oncological outcomes. PATIENTS AND METHODS: In the Agarwal loop-ligation technique, the distal ureteric stump is controlled using endoscopic Endoloop® or PolyLoop® ligation to ensure en bloc excision of the bladder cuff and prevent spillage of upper tract urine into the perivesical space. A retrospective review of the medical records of 76 patients who underwent the Agarwal loop-ligation technique for UTUC at participating centres from July 2004 to December 2017 was performed. Data collected included demographics, perioperative, and long-term oncological outcomes. Survival was calculated using Kaplan-Meier survival analyses. RESULTS AND LIMITATIONS: A total of 76 patients were included. The median age was 71.5 years and median operative time was 4.3 h. The intramural ureter and bladder cuff were completely excised in all patients. Distal surgical margins were clear in all, with only two patients found to have tumour extending to the circumferential surgical margin. There were no cases of perivesical recurrence or port-site metastasis. The 5-year bladder, local, and contralateral recurrence-free survival was 59.6%, 89.0% and 93.5%, respectively. Metastasis-free survival at 5-years was 73.5%. The 5-year overall survival and cancer-specific survival rates were 70.3% and 84.7%, respectively. CONCLUSIONS: We have described the Agarwal loop-ligation technique for the management of the distal ureter in LRNU. This technique complies with oncological principles outlined in the European Association of Urology guidelines, which minimises tumour spillage. Long-term oncological outcomes are satisfactory, with no cases of perivesical recurrence detected in this series.
引用
- Hoe V, Yao HH, Crozier J, et al. Long-term oncological outcomes of the Agarwal loop-ligation technique for management of the distal ureter during laparoscopic radical nephroureterectomy. BJU Int. 2021. PMID: 33305469. doi:10.1111/bju.15321
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。